Lefkowitz Steven W, Director, bought 20,000 shares of the CorMedix, Inc. (NYSE:CRMD) in an exchange that happened on December 20th. The stock was bought at an average price of $1.18 per share, amounting to a transaction worth $23,500. The purchase was made public in a document filed with the SEC. Additionally, Director Khan Mehmood bought 100,000 shares of this stock in a transaction that took place on December 20th. The stock was bought at an average price of $1.24 per share, for a total exchange amounting to $124,410. After the transaction, the Director Khan Mehmood currently holds 564,583 shares of the company’s stock, which is worth approximately $959791.
With this stock price’s latest movement, it is now -37.96% away from its 1-year high and 887.80% higher than its 1-year low price. In the past seven days, the stock price volatility for CorMedix, Inc. was 7.79%, whereas its volatility in the past 30 days has been 10.35%. This public company’s stock also has a beta score of 2.81. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
CorMedix, Inc. (NYSE:CRMD) most recently published its quarterly earnings results. The firm posted -$0.13 earnings per share (EPS) for the three-month period, missing analysts’ consensus estimate of -$0.11 by $0.02. The publicly-traded organization reported revenue of $0.12 million for the quarter, compared to the average analyst forecast calling for $0.14 million, which was missing the analyst consensus estimate.
Shares of CorMedix, Inc. (CRMD) surged 3.66%, amounting to a gain of $0.06 per share, to finish the regular trading session at $1.70 on Friday 03/01/2019. After beginning the session at $1.65, shares of CorMedix, Inc. reached as high as $1.75 during the day, while hitting a 1-day low of $1.62. Trade volume reached 1,633,953 shares against this stock’s average daily volume of 3.07M shares, with a total float of 100.34M. As a consequence of the price increase, CorMedix, Inc. now has a current market value of 194.36M.
Square, Inc. (NYSE:SQ) subtracted -4.65% to its trading price by the close of the most recent session, dropping from its previous closing price of $81.24 to $77.46. This stock increased in value by 1.81% during the last 7-day period, and experienced a gain of 8.29% over the past 30-day period. In the past three months, this stock’s price grew by 17.58% , and subtracted -4.13% to its price during the last six months of trading. SQ demonstrated a yearly price gain of 68.21% , while its year-to-date (YTD) price performance has been up 38.10% . This stock’s price changed by +55.48% compared to its 90-day low, and moved down -6.43% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the SQ stock as “Buy”. In the short-term, Square, Inc. (SQ) has a 20-day average volume of 12,584,360 shares and short-term indicators sets the SQ stock as “ 60% Buy ” on average basis. In the medium-term, SQ stock has a 50-Day average volume of 16,410,410 shares and medium-term indicators gave the average rating of “ 100% Buy ”, while in the long-term period the stock has a 100-Day average volume of 17,863,715 shares. On average, long-term indicators rated the stock as “33% Buy ”. The overall picture from all short, medium and long-term indicators sets the SQ stock as “72% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on SQ. Canaccord Genuity, for example, Reiterated its rating on shares of Square, Inc. to a “Buy”, while setting a $88 price target on shares of the company’s stock, according to a research note from Wednesday February 27th, 2019. while giving the stock a “ Underperform” from “Mkt Perform ” rating, as stated in a research report from Tuesday, January 29th, 2019. Nomura, on the other hand, Reiterated a “Buy” rating on this stock, while posting a $110 price target on shares of this company’s stock in a research note dated Thursday, January 24th, 2019.
In other news related to Square, Inc. stock, 70.34% shares of SQ held by institutions. The total number of institutions who held the SQ shares was 835, according to most recent SEC filling. During the past quarter, total 230,240,365 shares held by institutions with the net change of 9,928,314 shares. In the meantime, 171 new institutions bought the shares of Square, Inc. for the first time and 120 institutions sold all their holdings in the company’s common stock. 456 institutions increased their investment in the SQ stock and 358 institutions decreased their investment in the Square, Inc. (SQ)’s stock during the last quarter.